Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2Plasma cell 1Lymphoid 1Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Prostatic Neoplasms 35Motor Activity 25Breast Neoplasms 5Urinary Bladder Neoplasms 4Colorectal Neoplasms 4Neoplasms 3Fatigue 3Carcinoma, Renal Cell 3Ovarian Neoplasms 2Obesity 2Kidney Neoplasms 2Urologic Neoplasms 1Thyroid Neoplasms 1Testicular Neoplasms 1Smoking 1Sleep Initiation and Maintenance Disorders 1Risk Reduction Behavior 1Prostatectomy 1Postoperative Complications 1Peripheral Nervous System Diseases 1Patient Preference 1Neoplasm Metastasis 1Multiple Myeloma 1Metabolic Syndrome 1Mesothelioma, Malignant 1Malnutrition 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Insulin Resistance 1Hypoxia 1

Interventions

Magnetic Resonance Spectroscopy 4pembrolizumab 3Trastuzumab 3Sunitinib 3Nivolumab 3ulixertinib 2tipifarnib 2palbociclib 2lenvatinib 2belinostat 2Specimen Handling 2Sirolimus 2Radiosurgery 2Immunoglobulin G 2Fluorodeoxyglucose F18 2FAPI-46 2Disulfides 2vandetanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1trametinib 1tislelizumab 1temsirolimus 1spartalizumab 1sargramostim 1sapanisertib 1romidepsin 1relatlimab 1regorafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thyroid Neoplasms × Exercise × Genitourinary × Clear all
NCT04000880 2025-06-12

AMPLIFY

University of Alabama at Birmingham

Phase NA Active not recruiting
603 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidPlasma cell

Breast Neoplasms, Kidney Neoplasms, Lymphoma, Non-Hodgkin, Motor Activity, Multiple Myeloma, Ovarian Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡